This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1986 Jul;34(7):2852-8.

doi: 10.1248/cpb.34.2852.

Design and synthesis of N-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L -alanyl]-N-(indan-2-yl)glycine (CV-3317), a new, potent angiotensin converting enzyme inhibitor

A Miyake, K Itoh, Y Oka

PMID: 3021350
DOI: 10.1248/cpb.34.2852

Design and synthesis of N-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L -alanyl]-N-(indan-2-yl)glycine (CV-3317), a new, potent angiotensin converting enzyme inhibitor

A Miyake et al. Chem Pharm Bull (Tokyo). 1986 Jul.

. 1986 Jul;34(7):2852-8.

doi: 10.1248/cpb.34.2852.

Authors

A Miyake, K Itoh, Y Oka

PMID: 3021350
DOI: 10.1248/cpb.34.2852

No abstract available

PubMed Disclaimer

Similar articles

Synthesis and angiotension converting enzyme inhibitory activity of L-lysyl-N-substituted glycine derivatives.
Saito S, Matsui S, Fukushima S, Watanabe M, Waga T, Kajiwara Y, Shirota M, Iijima M, Kitabatake K. Saito S, et al. Arzneimittelforschung. 1989 Dec;39(12):1558-61. Arzneimittelforschung. 1989. PMID: 2560371
Inhibition of angiotensin converting enzyme by CV-3317, a non-sulfhydryl compound.
Inada Y, Terashita Z, Imura Y, Tanabe M, Nishikawa K, Kikuchi S. Inada Y, et al. Jpn J Pharmacol. 1986 Sep;42(1):99-108. doi: 10.1254/jjp.42.99. Jpn J Pharmacol. 1986. PMID: 3025487
Antihypertensive action of a non-sulfhydryl angiotensin converting enzyme inhibitor (CV-3317) in various hypertensive models.
Inada Y, Tanabe M, Shibouta Y, Kawazoe K, Nishikawa K, Kikuchi S. Inada Y, et al. Jpn J Pharmacol. 1986 Sep;42(1):1-8. doi: 10.1254/jjp.42.1. Jpn J Pharmacol. 1986. PMID: 3025485
Recent Advances in the Synthesis of Indanes and Indenes.
Gabriele B, Mancuso R, Veltri L. Gabriele B, et al. Chemistry. 2016 Apr 4;22(15):5056-94. doi: 10.1002/chem.201503933. Epub 2016 Jan 20. Chemistry. 2016. PMID: 26788795 Review.
Characteristics of a new angiotensin converting enzyme inhibitor: delapril.
Saruta T, Nishikawa K. Saruta T, et al. Am J Hypertens. 1991 Jan;4(1 Pt 2):23S-28S. doi: 10.1093/ajh/4.1.23s. Am J Hypertens. 1991. PMID: 2009144 Review.

See all similar articles

Cited by

Depressor effects and pharmacokinetics of single and consecutive doses of delapril in hypertensive patients with normal or impaired renal function.
Minamisawa K, Shionoiri H, Sugimoto K, Ueda S, Ashino K, Ebina T, Gotoh E, Ishii M. Minamisawa K, et al. Cardiovasc Drugs Ther. 1990 Oct;4(5):1417-23. doi: 10.1007/BF02018270. Cardiovasc Drugs Ther. 1990. PMID: 2177631
Bioavailability and pharmacokinetics of a fixed combination of delapril/indapamide following single and multiple dosing in healthy volunteers.
Hutt V, Pabst G, Dilger C, Poli G, Acerbi D. Hutt V, et al. Eur J Drug Metab Pharmacokinet. 1994 Jan-Mar;19(1):59-69. doi: 10.1007/BF03188824. Eur J Drug Metab Pharmacokinet. 1994. PMID: 7957454 Clinical Trial.

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database
Miscellaneous
- NCI CPTAC Assay Portal